Named as a key player in 132 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point Of Care (PoC) Molecular Diagnostic | Healthcare Services | $18.7 Bn | 9.3% |
| Nursing Education | Healthcare Services | $10.3 Bn | 8.1% |
| Breast Cancer Diagnostic | Healthcare Services | $4.1 Bn | 7.8% |
Named as key players in the same markets as Danaher Corporation (number of shared markets).
Siemens Healthineers4 shared markets
Thermo Fisher Scientific Inc.4 shared markets
Abbott Laboratories3 shared markets
Roche Diagnostics3 shared markets
Becton, Dickinson and Company (BD)2 shared markets
Hologic, Inc.2 shared markets
Qiagen N.V.2 shared markets